Comparison of Azithromycin and Pyrimethamine/sulfadiazine Treatment in Ocular Toxoplasmosis
Not Applicable
Recruiting
- Conditions
- Retinochoroiditis.Toxoplasma Oculopathy
- Registration Number
- IRCT201702146568N2
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
1. Presence of the retinal lesion at least 500 micrometers outside the center of the macula.
2. Lack of history of allergic reaction to the drugs used in this study.
3. Lack of any other ocular disease.
Exclusion criteria:
1. Visual acuity (VA) of lesser than 20/200
2. Location of the lesion within the center (500 micrometers) of the macula
3. Development of an allergic reaction to the medication
4. Leukopenia (white blood cell count lesser than 5000) or platelet count lesser than120 000/ml
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical improvement. Timepoint: One week, one month and three months after the first dose. Method of measurement: Ophthalmoscope.
- Secondary Outcome Measures
Name Time Method Visual acuity. Timepoint: One week, one month and three months after treatment. Method of measurement: Using the Snellen chart.;The recurrence rate. Timepoint: ?? 6 ??? ?? 2 ???. Method of measurement: Ophthalmoscope.